12
NEWS
Through the informational video series, JDRF aims
to support people to understand what treatments are
available and broaden access to technology that can
improve the lives of people with Type 1. The videos are
accompanied with information on the JDRF website about
each piece of technology, including who qualifies for
these treatments under current NHS guidance.
JDRF's senior technology access specialist Lesley
Jordan said, "With Type 1 diabetes, there are so many
things that can affect your glucose levels and a lot of daily
decisions, particularly if someone is newly diagnosed or
struggling to achieve their treatment targets and looking
to change treatments. These videos are a great resource
to help people understand what technology there is, how
it works and how it can benefit them."
To watch the videos, CLICK HERE.
SELF-STARTERS
DIY APS access, an update
Commenting in response to a paper published in The
Lancet Diabetes & Endocrinology in November 2021,
about guidance for people with Type 1 diabetes using
DIY technology to manage their condition, Diabetes
UK's policy manager Nikki Joule stated, "Do-it-yourself
artificial pancreas technology is a great example of
patient-led innovation and we know that growing
numbers of people with diabetes across the UK are
using it. Having international professional consensus
on this subject is important, and we hope UK regulators
will pay attention to these recommendations.
Particularly, we hope the Medicines and Healthcare
products Regulatory Authority (MHRA) will now seek
to provide clarity on their legal interpretations of this
technology. The ongoing MHRA consultation on the
regulation of medical devices is an ideal opportunity to
ensure they can do this."
The idea of DIY tech solutions may sound
disconcerting to many, but that's not the point, they are
here and possibly here to stay, so in the meantime says
Joules, "Diabetes UK understands why people choose to
turn to DIY closed-loop solutions, given that access to
regulated equivalents is very limited. We look forward
to the Scottish Health Technologies Group review
and National Institute for Health and Care Excellence
(NICE) appraisal of hybrid closed-loop systems, which
we hope will soon see more people accessing this lifechanging
technology in the NHS."